✦ LIBER ✦

148 Predictive factors of Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: analysis of diastolic function

✍ Scribed by Gaëtan Quilichini; Alexandre Cochet; Claude Touzery; Michel Toubeau; Inna Dygai-Cochet; Alina Berriolo-Riedinger; Renaud Ciappuccini; Olivier Humbert; Bruno Coudert; Yves Cottin; Francois Brunotte

Book ID: 119641076
Publisher: Elsevier
Year: 2010
Tongue: English
Weight: 79 KB
Volume: 2
Category: Article
ISSN: 1878-6480
DOI: 10.1016/s1878-6480(10)70150-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trastuzumab mediated cardiotoxicity in t

Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study

✍ Deepa Wadhwa; Nazanin Fallah-Rad; Debjani Grenier; Marianne Krahn; Tielan Fang; 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 198 KB

Baseline diastolic dysfunction as a pred

Baseline diastolic dysfunction as a predictive factor of trastuzumab-mediated cardiotoxicity after adjuvant anthracycline therapy in breast cancer

✍ Alexandre Cochet; Gaetan Quilichini; Inna Dygai-Cochet; Claude Touzery; Michel T 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 305 KB

Role of renal function on the developmen

Role of renal function on the development of cardiotoxicity associated with trastuzumab-based adjuvant chemotherapy for early breast cancer

✍ Giulia Russo, Giovanni Cioffi, Andrea Di Lenarda, Fausto Tuccia, Daniella Bovell 📂 Article 📅 2012 🏛 Springer Milan 🌐 English ⚖ 232 KB

Cost-effectiveness analysis of trastuzum

Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer

✍ Louis P. Garrison Jr; Deborah Lubeck; Deepa Lalla; Virginia Paton; Amylou Dueck; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views

## Abstract ## BACKGROUND. Adding trastuzumab to adjuvant chemotherapy provides significant clinical benefit in patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer. A cost‐effectiveness analysis was performed to assess clinical and economic implications of adding t

PCN20 COST-EFFECTIVENESS ANALYSIS OF ADJ

PCN20 COST-EFFECTIVENESS ANALYSIS OF ADJUVANT TRASTUZUMAB FOR TREATMENT OF HER2-POSITIVE EARLY BREAST CANCER IN THE SAUDI ARABIAN SETTING

✍ H AlOmar; AS Zazaa; M AlFayyadh; JA Ray 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

Analysis of Factors that Influence the A

Analysis of Factors that Influence the Accuracy of Magnetic Resonance Imaging for Predicting Response after Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

✍ Eun Sook Ko MD, Boo-Kyung Han MD, PhD, Rock Bum Kim MD, PhD, Eun Young Ko MD, Ph 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 309 KB